Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 22987029)

1.

Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries.

Ross JS, Wang R, Long JB, Gross CP, Ma X.

Arch Intern Med. 2012 Nov 12;172(20):1601-3. doi: 10.1001/archinternmed.2012.3726. No abstract available.

2.

2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.

Prasad SM, Drazer MW, Huo D, Hu JC, Eggener SE.

JAMA. 2012 Apr 25;307(16):1692-4. doi: 10.1001/jama.2012.534. No abstract available.

PMID:
22535850
3.

Grading the new US Preventive Services Task Force prostate cancer screening recommendation.

Volk RJ, Wolf AM.

JAMA. 2011 Dec 28;306(24):2715-6. doi: 10.1001/jama.2011.1893. No abstract available.

PMID:
22203540
4.

The politics of prostate cancer screening.

Kaffenberger SD, Penson DF.

Urol Clin North Am. 2014 May;41(2):249-55. doi: 10.1016/j.ucl.2014.01.004. Epub 2014 Feb 19.

5.

The impact of recent screening recommendations on prostate cancer screening in a large health care system.

Aslani A, Minnillo BJ, Johnson B, Cherullo EE, Ponsky LE, Abouassaly R.

J Urol. 2014 Jun;191(6):1737-42. doi: 10.1016/j.juro.2013.12.010. Epub 2013 Dec 14.

PMID:
24342148
6.

Response to the U.S. Preventative Services Task Force decision on prostate cancer screening.

Makovey I, Stephenson AJ, Haywood S.

Curr Urol Rep. 2013 Jun;14(3):168-73. doi: 10.1007/s11934-013-0318-9.

PMID:
23568623
7.

Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.

Schröder FH.

N Engl J Med. 2011 Nov 24;365(21):1953-5. doi: 10.1056/NEJMp1112140. Epub 2011 Oct 26. No abstract available.

8.

Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.

Brett AS, Ablin RJ.

N Engl J Med. 2011 Nov 24;365(21):1949-51. doi: 10.1056/NEJMp1112191. Epub 2011 Oct 26. No abstract available.

9.

Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation.

Cohn JA, Wang CE, Lakeman JC, Silverstein JC, Brendler CB, Novakovic KR, McGuire MS, Helfand BT.

Urol Oncol. 2014 Jan;32(1):41.e23-30. doi: 10.1016/j.urolonc.2013.04.013. Epub 2013 Aug 2.

PMID:
23911680
10.

Comment on the US Preventive Services Task Force's draft recommendation on screening for prostate cancer.

Kwiatkowski M, Klotz L, Hugosson J, Recker F.

Eur Urol. 2012 Apr;61(4):851-4. doi: 10.1016/j.eururo.2012.01.023. Epub 2012 Jan 24. No abstract available.

PMID:
22285762
11.

Serious health events and discontinuation of routine cancer screening.

Howard DH, Huang YL.

Med Decis Making. 2012 Jul-Aug;32(4):627-35. doi: 10.1177/0272989X11434600. Epub 2012 Jan 27.

PMID:
22287535
12.

Evolution and immediate future of US screening guidelines.

Greene KL, Punnen S, Carroll PR.

Urol Clin North Am. 2014 May;41(2):229-35. doi: 10.1016/j.ucl.2014.01.005. Review.

PMID:
24725485
13.

Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part I: Framing the debate.

Barry MJ, Fleming C, Coley CM, Wasson JH, Fahs MC, Oesterling JE.

Urology. 1995 Jul;46(1):2-13. No abstract available.

PMID:
7541583
14.

Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation.

Howard DH, Tangka FK, Guy GP, Ekwueme DU, Lipscomb J.

Health Aff (Millwood). 2013 Mar;32(3):596-602. doi: 10.1377/hlthaff.2012.0555.

PMID:
23459740
15.

Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review.

Carlsson S, Vickers AJ, Roobol M, Eastham J, Scardino P, Lilja H, Hugosson J.

J Clin Oncol. 2012 Jul 20;30(21):2581-4. doi: 10.1200/JCO.2011.40.4327. Epub 2012 Jun 18. No abstract available.

16.

The cost implications of prostate cancer screening in the Medicare population.

Ma X, Wang R, Long JB, Ross JS, Soulos PR, Yu JB, Makarov DV, Gold HT, Gross CP.

Cancer. 2014 Jan 1;120(1):96-102. doi: 10.1002/cncr.28373. Epub 2013 Oct 4.

17.

The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.

Ablin RJ.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):391-4. doi: 10.1158/1055-9965.EPI-12-0058. Epub 2012 Feb 7. No abstract available.

18.

Patient preferences in breast cancer screening: lessons to be learned from the US Preventive Services Task Force.

Sadigh G, Kelly AM, Fagerlin A, Carlos RC.

Acad Radiol. 2011 Nov;18(11):1333-6. doi: 10.1016/j.acra.2011.07.001. Epub 2011 Aug 10. No abstract available.

PMID:
21835650
19.

Words of wisdom: Re: Screening for prostate cancer: US Preventive Services Task Force recommendation statement.

Albertsen PC.

Eur Urol. 2013 Sep;64(3):512. doi: 10.1016/j.eururo.2013.06.027. No abstract available.

PMID:
23915461
20.

The Society of Urologic Oncology's reply to the US Preventative Services Task Force's recommendation on PSA testing.

Messing EM, Albertsen P, Andriole GL Jr, Carroll PR, Klein EA.

Urol Oncol. 2012 Jan-Feb;30(1):117-9. doi: 10.1016/j.urolonc.2011.12.010. No abstract available.

PMID:
22243597
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk